Molcure

Molcure is antibody-drug-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of patients by developing and providing more effective therapeutics and supportive care products. Molcure represents high quality antibody and target discovery. With cutting edge technology in-house, Molcure is the partner of choice for therapeutic antibody discovery. At Molcure we combine a deep knowledge of NGS, bioinformatics and antibody biology with automated discovery system. The antibody discovery platform Abtracer delivers superior functional antibodies. Our technology is validated through a number of partnerships. Abtracer is a patent pending, rapid antibody engineering system which combines the Phage Display technique and next generation sequencing. We can design DNA sequence of antibodies with high-affinity and high-specificity by NGS-analysis of antibody DNA sequences using machine learning algorithm.